Synpromics


Synpromics logo

Synpromics gives researchers, developers and manufacturers unprecedented control of gene expression through proprietary technology that yields highly specific and active synthetic promoters, thus facilitating a competitive IP position for our partners.

Synpromics' designs and develops patentable synthetic promoters that are designed to regulate genes in a highly specific manner. Given that these promoters greatly improve upon the natural promoters on which the entire biotech industry currently relies, there is enormous potential for the company to drive the Biotech industry forward and transform the entire sector.

Contact Synpromics via their website


News Archive

19/04/2017   Synpromics raises £5.2m of new investment...more
16/03/2017   Synpromics Granted Key Patent in Synthetic Promoter Development...more
04/01/2017   Synpromics announces research collaboration with GE Healthcare...more
04/01/2017   Synpromics Announces Research Collaboration with GE Healthcare...more

07/12/2016   Synpromics Announces Expansion of Research Collaboration with Adverum Biotechnologies...more
22/06/2016   Synpromics announces extension to collaboration with uniQure...more
19/04/2016   Synpromics Further Strengthens Board and Management Team...more
11/01/2016   Synpromics and Cell Therapy Catapult announce collaboration...more

09/12/2015   AGTC and Synpromics Limited Announce R&D Collaboration...more
14/08/2015   Synpromics receives £2.1m from EIS specialist Calculus Capital...more
05/03/2015   Synpromics Announces New Collaboration...more

20/08/2014   Synpromics announces new synthetic promoters for use in plants...more

03/10/2013   Dow AgroSciences and Synpromics Announce R&D Collaboration...more
01/10/2013   Synpromics joins the first UK synthetic biology trade mission...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

United Life Sciences





Accredited by



Partners

Scottish Development International


Preferred suppliers

APH

Arcinova

Club Quarters Hotels

Embassy Freight exhibition freighting

UK Forex foreign exchange transaction services

Precision Oncology

YourEncore